In Vitro Diagnostics (IVD) Market Outlook in China

In Vitro Diagnostics (IVD) Market Outlook in China

RELEASE DATE
06-Aug-2013
REGION
Asia Pacific
Research Code: P706-01-00-00-00
SKU: LS00059-AP-MR_16900
AvailableYesPDF Download
$4,950.00
In stock
SKU
LS00059-AP-MR_16900
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.

Table of Contents

Executive Summary

Executive Summary (continued)

Executive Summary—Market Engineering Measurements

Past, Present, and Future IVD Market in China

Snapshot of Potential Opportunities

Opportunities in Emerging Segments

Market Overview—Segmentation by Testing Principle

Market Overview—Segmentation(continued)

Market Overview—Segmentation (continued)

Market Life Cycle

Healthcare Structure and Financing in China

Overview of the Chinese Medical Insurance System

Overview of the Chinese Medical Insurance System (continued)

Approval of IVD Products

Procurement of IVD Products

Reimbursement and Price Caps

In Vitro Diagnostics Overview

Drivers and Restraints

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Total IVD Market —Market Engineering Measurements

Forecast Assumptions

Total IVD Market—Revenue Forecast

Revenue Forecast Discussion

Multinational and Local Participants

Foreign enterprises have already achieved stable market shares

Leading Local suppliers more flexible on their sales strategy

Distribution Model of IVD Industry

Feature Analysis of the Chinese Health Institution and Central Labs

Develop substitution for imported devices: short-cut for local leading manufacturers

Competitive Analysis—Market Share

Market Share Analysis

Market Share Analysis(continued)

Molecular Diagnostics Segment—Revenue Forecast

Molecular Diagnostics Segment—Revenue Forecast Discussion

Clinical Chemistry Segment—Revenue Forecast

Clinical Chemistry Segment—Revenue Forecast Discussion

Immunoassay Segment—Revenue Forecast

Immunoassay Segment—Revenue Forecast Discussion

Microbiology Segment—Revenue Forecast

Microbiology Segment—Revenue Forecast Discussion

POCT Segment—Revenue Forecast

POCT Segment—Revenue Forecast Discussion

Coagulation Segment—Revenue Forecast

Coagulation Segment—Revenue Forecast Discussion

SMBG Segment—Revenue Forecast

SMBG Segment—Revenue Forecast Discussion

Hematology Segment—Revenue Forecast

Hematology Segment—Revenue Forecast Discussion

Conclusions

Recommendations

Legal Disclaimer

Who is Frost & Sullivan

What Makes Us Unique

TEAM Methodology

Our Global Footprint 40+ Offices

Related Research
The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.
More Information
No Index No
Podcast No
WIP Number P706-01-00-00-00
Is Prebook No